Vivotif - Norveška - norveščina - Statens legemiddelverk

vivotif -

bavarian nordic a/s - salmonella enterica, serovar typhi ty21a, levende - enterokapsel, hard

Typhim Vi 25 mikrog/0.5 ml Norveška - norveščina - Statens legemiddelverk

typhim vi 25 mikrog/0.5 ml

sanofi pasteur europe - salmonella enterica, serovar typhi, stamme ty2, vi polysakkarid - injeksjonsvæske, oppløsning - 25 mikrog/0.5 ml

ViATIM 25 mikrog/ dose / 160 E/ dose Norveška - norveščina - Statens legemiddelverk

viatim 25 mikrog/ dose / 160 e/ dose

sanofi pasteur europe - salmonella typhi vi polysakkarid / hepatitt a-virus, inaktivert - injeksjonsvæske, suspensjon - 25 mikrog/ dose / 160 e/ dose

Vivotif - Norveška - norveščina - Statens legemiddelverk

vivotif -

paxvax ltd. - salmonella typhi vi polysakkarid - enterokapsel, hard

Cleave Norveška - norveščina - Adama

cleave

adama - florasulam 2,5 g/l (0,25 vikt-%) + fluroksypyr-1-metylheptylester 144 g/l (14.2 vikt-%) - ugrasmiddel

Agil 100 EC Norveška - norveščina - Adama

agil 100 ec

adama - propakvizafop 100 g/l - ugrasmiddel

Lopacut 2 mg Norveška - norveščina - Statens legemiddelverk

lopacut 2 mg

vitabalans oy - loperamidhydroklorid - tablett, filmdrasjert - 2 mg

Shingrix Evropska unija - norveščina - EMA (European Medicines Agency)

shingrix

glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e - herpes zoster - vaksiner - shingrix is indicated for prevention of herpes zoster (hz) and post-herpetic neuralgia (phn), in:adults 50 years of age or older;adults 18 years of age or older at increased risk of hz. bruk av shingrix skal være i samsvar med offisielle anbefalinger.

Arexvy Evropska unija - norveščina - EMA (European Medicines Agency)

arexvy

glaxosmithkline biologicals s.a.  - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - respiratorisk syncytialvirusinfeksjoner - vaksiner - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. bruk av denne vaksinen skal være i samsvar med offisielle anbefalinger.

Mixin Norveška - norveščina - Adama

mixin

adama - florasulam 2,5 g/l (0,25 vikt-%) + fluroksypyr-1-metylheptylester 144 g/l (14.2 vikt-%) - ugrasmiddel